Colchicine in Atrial Fibrillation to Prevent Stroke "CIAFS-1"

Not yet recruiting

Phase 3 Results N/A

Summary of Purpose

The purpose of this study is to determine the feasibility of performing a randomized controlled trial to investigate the efficacy of an anti-inflammatory drug, colchicine, at reducing well validated markers of thrombosis (D-dimer) and inflammation (hs-CRP).

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 30 October 2014.

1 Nov 2014 29 Oct 2014 1 Jun 2016 1 Jun 2016 1 Oct 2014 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Conditions

Sponsors

Trial Design

  • Allocation: Randomized
  • Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor)
  • Purpose: Prevention
  • Endpoint: Safety/Efficacy Study
  • Intervention: Parallel Assignment

Contacts